iShares Global Healthcare ETF (IXJ)
83.02
+1.10 (+1.34%)
USD |
NYSEARCA |
May 20, 16:00
83.03
+0.01 (+0.01%)
After-Hours: 20:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.43% | 0.16% | 3.485B | 202568.5 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 1.22% | 5.00% | 519.83M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to track the S&P Global 1200 Health Care IndexTM. The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| S&P Global 1200 Healthcare Sector NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 14.34 yrs |
| Jennifer Hsui | 9.75 yrs |
| Amy Whitelaw | 3.75 yrs |
| Paul Whitehead | 0.33 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
3
519.83M
-3.360B
Category Low
9.492B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 20, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 20, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Johnson & Johnson | 6.70% | 176.98 | 1.75% |
| UnitedHealth Group Inc | 6.60% | 485.73 | 1.50% |
| Pfizer Inc | 4.16% | 52.47 | 3.59% |
| AbbVie Inc | 3.93% | 151.01 | -0.47% |
| Merck & Co Inc | 3.41% | 93.55 | 1.59% |
|
Roche Holding AG
|
3.35% | -- | -- |
| Eli Lilly and Co | 3.33% | 298.85 | 4.39% |
| Thermo Fisher Scientific Inc | 3.18% | 555.15 | 0.80% |
|
Novartis AG
|
3.14% | -- | -- |
| Abbott Laboratories | 2.91% | 113.24 | 0.71% |
News
Headline
Wire
Time (ET)
SA Breaking News
11/27 08:04
SA Breaking News
06/10 15:02
Basic Info
| Investment Strategy | |
| The investment seeks to track the S&P Global 1200 Health Care IndexTM. The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| S&P Global 1200 Healthcare Sector NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 14.34 yrs |
| Jennifer Hsui | 9.75 yrs |
| Amy Whitelaw | 3.75 yrs |
| Paul Whitehead | 0.33 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-20-22) | 1.22% |
| 30-Day SEC Yield (3-31-22) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 22.36 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of May 19, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 11/13/2001 |
| Last Annual Report Date | 3/31/2021 |
| Last Prospectus Date | 7/30/2021 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
SA Breaking News
11/27 08:04
SA Breaking News
06/10 15:02